RTRAF and cervical cancer: These studies indicate that overexpression of C14ORF166 may affect the development and progression of cervical cancer by modulating the JAK2/STAT3 signaling pathways; further characterization of these processes may provide new insight and novel targets for the treatment of cervical cancer.